10 Health Care Stocks to Watch
The Street
Checking the Quality of Gilead's Growth
Motley Fool
Gilead Announces Positive Five-Year Data Showing Effect of Viread® on Liver Fibrosis and Cirrhosis Caused by Chronic Hepatitis B
Yahoo/BusinessWire
A Little Help, Please (Gilead Sciences)
Motley Fool
Good Biotech Stocks for a Bear Market
TheStreet.com
Biotech Calendar: Key Dates for August
TheStreet.com

